Notice to Extend the Expiration Date for PAR-25-096 "Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trial Not Allowed)"

About this opportunity

The purpose of this Notice is to extend the expiration date for PAR-25-096, "Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trial Not Allowed)". Therefore, with the addition/extension by one Application Due Date, PAR-25-096 now expires on November 17, 2026. The following sections in Part 1. Overview Information, Key Dates section have been changed: Currently reads and modified to read (in bold italics):